Insmed Incorporated
NASDAQ:INSM
Overview | Financials
Company Name | Insmed Incorporated |
Symbol | INSM |
Currency | USD |
Price | 68.32 |
Market Cap | 11,740,723,680 |
Dividend Yield | 0% |
52-week-range | 21.92 - 80.53 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. William H. Lewis J.D., M.B.A. |
Website | https://www.insmed.com |
An error occurred while fetching data.
About Insmed Incorporated
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD